InsiderClue
Insiders · Profile

Parrish Jay

Chief Business Officer at Vir Biotechnology. Filing since 14 May 2020. CIK 0001786372

Company
Date
Role
Action
Shares
Amount
Of holding
VIR Vir Biotechnology, Inc.
1 Apr 2021
Chief Business Officer
Sold, plan not stated
6,944
$356.96K
42.9%
VIR Vir Biotechnology, Inc.
1 Mar 2021
Chief Business Officer
Sold, plan not stated
6,944
$440.53K
42.9%
VIR Vir Biotechnology, Inc.
1 Feb 2021
Chief Business Officer
Sold, plan not stated
6,944
$485.42K
3.0%
VIR Vir Biotechnology, Inc.
4 Jan 2021
Chief Business Officer
Sold, plan not stated
6,945
$182.80K
3.0%
VIR Vir Biotechnology, Inc.
1 Dec 2020
Chief Business Officer
Sold, plan not stated
6,945
$218.97K
3.0%
VIR Vir Biotechnology, Inc.
2 Nov 2020
Chief Business Officer
Sold, plan not stated
6,944
$217.15K
3.0%
VIR Vir Biotechnology, Inc.
1 Oct 2020
Chief Business Officer
Sold, plan not stated
6,945
$241.34K
3.0%
VIR Vir Biotechnology, Inc.
1 Sep 2020
Chief Business Officer
Sold, plan not stated
6,943
$271.80K
3.0%
VIR Vir Biotechnology, Inc.
3 Aug 2020
Chief Business Officer
Sold, plan not stated
11,110
$529.40K
4.8%
VIR Vir Biotechnology, Inc.
1 Jul 2020
Chief Business Officer
Sold, plan not stated
75,000
$2.85M
25.2%
VIR Vir Biotechnology, Inc.
1 Jun 2020
Chief Business Officer
Sold, plan not stated
75,000
$2.64M
25.2%
VIR Vir Biotechnology, Inc.
14 May 2020
Chief Business Officer
Sold, plan not stated
75,000
$2.25M
25.2%
12 decisions on file.